SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-17-005835
Filing Date
2017-04-03
Accepted
2017-04-03 08:38:59
Documents
3
Period of Report
2017-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dffn20170402_8k.htm 8-K 36516
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 14196
3 ex99-1img001.jpg GRAPHIC 4079
  Complete submission text file 0001437749-17-005835.txt   57996
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 17732392
SIC: 2834 Pharmaceutical Preparations